방사선생물학

본문글자크기
  • [J Cell Physiol. ] The Small Molecule AU14022 Promotes Colorectal Cancer Cell Death via p53-mediated G2/M-phase Arrest and Mitochondria-mediated Apoptosis.

    KIRAMS/ 류화니, 남기엽, 안지연*, 송지영*

  • 출처
    J Cell Physiol.
  • 등재일
    2017 Oct 14
  • 저널이슈번호
    doi: 10.1002/jcp.26234. [Epub ahead of print]
  • 내용

    바로가기  >

    Abstract

    The p53 tumor suppressor plays critical roles in cell cycle regulation and apoptotic cell death, with its activation capable of sensitizing cancer cells to radiotherapy or chemotherapy. To identify small molecules that induce apoptosis via increased p53 transcriptional activity, we used a novel in-house library containing 96 small-molecule compounds. Using a cell-based screening method with a p53-responsive luciferase-reporter assay system involving benzoxazole derivatives, we found that AU14022 administration significantly increased p53 transcriptional activity in a concentration-dependent manner. Treatment with AU14022 increased p53 protein expression, p53 Ser15 phosphorylation, p53-mediated expression of downstream target genes, and apoptosis in p53-wild-type HCT116 human colon cancer cells, but not in p53-knockout HCT116 cells. Additionally, p53-wild-type HCT116 cells treated with AU14022 exhibited mitochondrial dysfunction, including modulated expression of B-cell lymphoma-2 family proteins and cytochrome c release. Combination treatment with AU14022 and ionizing radiation (IR) synergistically induced apoptosis as compared with IR or AU14022 treatment alone, with further investigation demonstrating that cell cycle progression was significantly arrested at the G2/M phase following AU14022 treatment. Furthermore, in a mouse p53-wild-type HCT116 colon cancer xenograft model, combined treatment with AU14022 and IR inhibited tumor growth more effectively than radiation alone. Therefore, AU14022 treatment induced apoptosis through p53-mediated cell cycle arrest involving mitochondrial dysfunction, leading to enhanced radiosensitivity in colon cancer cells. These results provide a basis for further assessments of AU14022 as a promising anticancer agent. 

     

    Author information

    Ryu H1, Nam KY2, Kim JS1, Hwang SG1, Song JY1, Ahn J1.

    1Division of Radiation Cancer Research, Korea Institute of Radiological & Medical Sciences, Seoul 01812, Korea.2Research center, Pharos I&BT Co., Ltd., Anyang 14059, Korea. 

  • 키워드
    apoptosis; benzoxazole derivative; cell cycle arrest; mitochondria; p53
  • 덧글달기
    덧글달기
       IP : 3.145.15.1

    등록